Back to search results

Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)

Abroad (travel likely)RecruitingPHASE2

Conditions

Hepatocellular Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

    Contact: Study coordinator (Mian Xi, MD) · ximian@sysucc.org.cn · +862087343385
    Contact: Principal Investigator (Mian Xi, MD)
    Qi Zeng, MD (Sub-investigator)
    Yi Lu, MD (Sub-investigator)
Study leads

  • Mian Xi, MD

    Principal Investigator

    Sun Yat-Sen University Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)